Firefly Neuroscience (AIFF) Stock Overview
A medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
AIFF Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Firefly Neuroscience, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.67 |
| 52 Week High | US$17.20 |
| 52 Week Low | US$1.86 |
| Beta | 0 |
| 1 Month Change | -4.30% |
| 3 Month Change | -12.17% |
| 1 Year Change | -29.72% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -68.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| AIFF | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 1.5% | -5.1% | -0.6% |
| 1Y | -29.7% | 17.6% | 18.1% |
Return vs Industry: AIFF underperformed the US Healthcare Services industry which returned 18% over the past year.
Return vs Market: AIFF underperformed the US Market which returned 17.5% over the past year.
Price Volatility
| AIFF volatility | |
|---|---|
| AIFF Average Weekly Movement | 7.8% |
| Healthcare Services Industry Average Movement | 9.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.1% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AIFF has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: AIFF's weekly volatility has decreased from 32% to 8% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 13 | Greg Lipschitz | fireflyneuro.com |
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners.
Firefly Neuroscience, Inc. Fundamentals Summary
| AIFF fundamental statistics | |
|---|---|
| Market cap | US$36.16m |
| Earnings (TTM) | -US$27.25m |
| Revenue (TTM) | US$428.00k |
Is AIFF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AIFF income statement (TTM) | |
|---|---|
| Revenue | US$428.00k |
| Cost of Revenue | US$25.00k |
| Gross Profit | US$403.00k |
| Other Expenses | US$27.65m |
| Earnings | -US$27.25m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.03 |
| Gross Margin | 94.16% |
| Net Profit Margin | -6,366.12% |
| Debt/Equity Ratio | 0% |
How did AIFF perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/03 06:06 |
| End of Day Share Price | 2025/09/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Firefly Neuroscience, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.